Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells
暂无分享,去创建一个
Minshan Chen | D. Kuang | Qiyi Zhao | Limin Zheng | Yan Wu | C. Peng
[1] Jing Xu,et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 , 2009, The Journal of experimental medicine.
[2] J. Xu,et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. , 2009, Journal of Hepatology.
[3] J. Xu,et al. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. , 2009, Human pathology.
[4] G. Galbraith. IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation , 2009 .
[5] Wan-Wan Lin,et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis , 2009, Nature.
[6] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[7] Wen-rong Gong,et al. Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development1 , 2008, The Journal of Immunology.
[8] S. Alzabin,et al. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells , 2008, The Journal of experimental medicine.
[9] Warren Strober,et al. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.
[10] K. Odunsi,et al. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer , 2008, Proceedings of the National Academy of Sciences.
[11] J. Yun,et al. Tumor-Educated Tolerogenic Dendritic Cells Induce CD3ε Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways1 , 2008, The Journal of Immunology.
[12] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[13] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[14] E. Barillot,et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.
[15] Chen Dong,et al. TH17 cells in development: an updated view of their molecular identity and genetic programming , 2008, Nature Reviews Immunology.
[16] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[17] M. McGeachy,et al. Review Th17 Cell Differentiation: the Long and Winding Road , 2022 .
[18] Wen-rong Gong,et al. Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. , 2008, Journal of immunology.
[19] D. Hommes,et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.
[20] Graham M Lord,et al. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes , 2007, Proceedings of the National Academy of Sciences.
[21] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[22] Jiasen Cheng,et al. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. , 2007, Blood.
[23] Zheng Zhang,et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.
[24] A. Chang,et al. Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment1 , 2007, The Journal of Immunology.
[25] H. Moses,et al. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. , 2007, The Journal of clinical investigation.
[26] R. Kastelein,et al. Swords into plowshares: IL-23 repurposes tumor immune surveillance. , 2007, Trends in immunology.
[27] G. Rabinovich,et al. Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.
[28] Xin Wei Wang,et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. , 2006, Cancer cell.
[29] Gefeng Zhu,et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma , 2006, The Journal of experimental medicine.
[30] L. Coussens,et al. Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.
[31] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[32] R. Sun,et al. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Dufour,et al. Angiogenesis and hepatocellular carcinoma. , 2004, Journal of hepatology.
[34] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[35] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[36] J. Lötvall,et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.
[37] D. Laskin,et al. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. , 1995, American journal of respiratory cell and molecular biology.